Tables by site (3-digit category)

These tables present the total number of cases, the world age-standardized incidence rates (ASR(W)), and the cumulative rates for age 0–74 years (CUM 0–74), with their standard errors, for each of the cancer sites presented in the registry summary tables and for colon and rectum and for all of the leukaemias.

• All sites (C00–96)
• All sites except non–melanoma skin cancer (C00–96/C44)
• Oral cavity and pharynx
  • Lip (C00)
  • Tongue (C01–02)
  • Mouth (C03–06)
  • Salivary glands (C07–08)
  • Tonsil (C09)
  • Other oropharynx (C10)
  • Nasopharynx (C11)
  • Hypopharynx (C12–13)
  • Pharynx unspecified (C14)
• Digestive organs
  • Oesophagus (C15)
  • Stomach (C16)
  • Small intestine (C17)
  • Large bowel (C18–21)
  • Colon and rectum (C18–20)
  • Colon (C18)
  • Rectum (C19–20)
  • Anus (C21)
  • Liver (C22)
  • Gallbladder etc. (C23–24)
  • Pancreas (C25)
• Respiratory and other intrathoracic organs
  • Nose, sinuses etc. (C30–31)
  • Larynx (C32)
  • Trachea, bronchus and lung (C33–34)
  • Other thoracic organs (C37–38)
  • Head and neck (C00–14,C30–32)
• Bone, skin, mesothelial and soft tissue
  • Bone (C40–41)
  • Melanoma of skin (C43)
  • Other skin (C44)
  • Mesothelioma (C45)
  • Kaposi sarcoma (C46)
  • Connective and soft tissue (C47+C49)
• Breast (C50)
• Female genital organs
  • Vulva (C51)
  • Vagina (C52)
  • Cervix uteri (C53)
  • Corpus uteri (C54)
  • Uterus unspecified (C55)
  • Ovary (C56)
  • Other female genital organs (C57)
  • Placenta (C58)
• Male genital organs
  • Penis (C60)
  • Prostate (C61)
  • Testis (C62)
  • Other male genital organs (C63)
• Urinary organs
  • Kidney (C64)
  • Renal pelvis (C65)
  • Ureter (C66)
  • Bladder (C67)
  • Other urinary organs
• Eye, brain, central nervous system, thyroid and other endocrine glands
  • Eye (C69)
  • Brain, central nervous system (C70–72)
  • Thyroid (C73)
  • Adrenal gland (C74)
  • Other endocrine (C75)
• Lymphoid, haematopoietic and related tissue
  • Hodgkin lymphoma (C81)
  • Non–Hodgkin lymphoma (C82–86,C96)
  • Immunoproliferative diseases (C88)
  • Multiple myeloma (C90)
  • Leukaemia (C91–95)
  • Lymphoid leukaemia (C91)
  • Myeloid leukaemia (C92–94)
  • Leukaemia unspecified (C95)
  • Myeloproliferative disorders (MPD)
  • Myelodysplastic syndromes (MDS)
• Other and unspecified sites (O&U)

• - (dash) = no cases registered or the cumulative rate cannot be computed.
• 0.0 = the age-standardized rate is greater than 0 but less than 0.05.
• 0.00 = the cumulative rate or standard error is greater than 0 but less than 0.005.

The Age-Standardized Incidence Rate is printed in bold and the standard errors are in italic.